U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    LINC01133 long intergenic non-protein coding RNA 1133 [ Homo sapiens (human) ]

    Gene ID: 100505633, updated on 4-Dec-2023

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    LINC01133 can induce acquired ferroptosis resistance by enhancing the FSP1 mRNA stability through forming the LINC01133-FUS-FSP1 complex.

    LINC01133 can induce acquired ferroptosis resistance by enhancing the FSP1 mRNA stability through forming the LINC01133-FUS-FSP1 complex.
    Wang S, Chen J, Li P, Chen Y., Free PMC Article

    11/29/2023
    A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis.

    A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis.
    Li J, Lin J, Ji Y, Wang X, Fu D, Wang W, Shen B., Free PMC Article

    11/20/2023
    [Long non-coding RNA LINC01133 regulates cementogenic differentiation of human periodontal ligament stem cells by modulating mitochondrial functions].

    [Long non-coding RNA LINC01133 regulates cementogenic differentiation of human periodontal ligament stem cells by modulating mitochondrial functions].
    Deng DK, Li X, He XT, Sun HH, Tian BM, Chen FM.

    12/24/2022
    Linc01133 promotes proliferation and metastasis of human renal cell carcinoma through sponging miR-760.

    Linc01133 promotes proliferation and metastasis of human renal cell carcinoma through sponging miR-760.
    Lv W, Li Y, Fu L, Meng F, Li J., Free PMC Article

    07/16/2022
    Clinical potential of long non-coding RNA LINC01133 as a promising biomarker and therapeutic target in cancers.

    Clinical potential of long non-coding RNA LINC01133 as a promising biomarker and therapeutic target in cancers.
    Sharma U, Barwal TS, Murmu M, Acharya V, Pant N, Dey D, Vivek, Gautam A, Bazala S, Singh I, Azzouz F, Bishayee A, Jain A.

    05/14/2022
    Role of LINC01133 in Osteogenic Differentiation of Dental Pulp Stem Cells by Targeting miR-199b-5p.

    Role of LINC01133 in Osteogenic Differentiation of Dental Pulp Stem Cells by Targeting miR-199b-5p.
    Shi Q, Zheng M.

    05/7/2022
    Linc01133 contributes to gastric cancer growth by enhancing YES1-dependent YAP1 nuclear translocation via sponging miR-145-5p.

    Linc01133 contributes to gastric cancer growth by enhancing YES1-dependent YAP1 nuclear translocation via sponging miR-145-5p.
    Sun Y, Tian Y, He J, Tian Y, Zhang G, Zhao R, Zhu WJ, Gao P., Free PMC Article

    04/16/2022
    LINC01133 hampers the development of gastric cancer through increasing somatostatin via binding to microRNA-576-5p.

    LINC01133 hampers the development of gastric cancer through increasing somatostatin via binding to microRNA-576-5p.
    Zhang L, Pan K, Zuo Z, Ye F, Cao D, Peng Y, Tang T, Li X, Zhou S, Duan L.

    03/26/2022
    LINC01133 promotes hepatocellular carcinoma progression by sponging miR-199a-5p and activating annexin A2.

    LINC01133 promotes hepatocellular carcinoma progression by sponging miR-199a-5p and activating annexin A2.
    Yin D, Hu ZQ, Luo CB, Wang XY, Xin HY, Sun RQ, Wang PC, Li J, Fan J, Zhou ZJ, Zhou J, Zhou SL., Free PMC Article

    01/22/2022
    Exosomes-mediated transfer of long noncoding RNA LINC01133 represses bladder cancer progression via regulating the Wnt signaling pathway.

    Exosomes-mediated transfer of long noncoding RNA LINC01133 represses bladder cancer progression via regulating the Wnt signaling pathway.
    Yang H, Qu H, Huang H, Mu Z, Mao M, Xie Q, Wang K, Hu B.

    12/11/2021
    MiR-216a-5p inhibits tumorigenesis in Pancreatic Cancer by targeting TPT1/mTORC1 and is mediated by LINC01133.

    MiR-216a-5p inhibits tumorigenesis in Pancreatic Cancer by targeting TPT1/mTORC1 and is mediated by LINC01133.
    Zhang J, Gao S, Zhang Y, Yi H, Xu M, Xu J, Liu H, Ding Z, He H, Wang H, Hao Z, Sun L, Liu Y, Wei F., Free PMC Article

    11/27/2021
    LINC01133 Inhibits Invasion and Promotes Proliferation in an Endometriosis Epithelial Cell Line.

    LINC01133 Inhibits Invasion and Promotes Proliferation in an Endometriosis Epithelial Cell Line.
    Yotova I, Hudson QJ, Pauler FM, Proestling K, Haslinger I, Kuessel L, Perricos A, Husslein H, Wenzl R., Free PMC Article

    09/25/2021
    Sevoflurane protects cardiomyocytes against hypoxia/reperfusion injury via LINC01133/miR-30a-5p axis.

    Sevoflurane protects cardiomyocytes against hypoxia/reperfusion injury via LINC01133/miR-30a-5p axis.
    Yu Z, Ren Q, Yu S, Gao X., Free PMC Article

    04/17/2021
    LINC01133 contribute to epithelial ovarian cancer metastasis by regulating miR-495-3p/TPD52 axis.

    LINC01133 contribute to epithelial ovarian cancer metastasis by regulating miR-495-3p/TPD52 axis.
    Liu S, Xi X.

    03/28/2021
    Hydrostatic pressure induces osteogenic differentiation of adipose-derived mesenchymal stem cells through increasing lncRNA-PAGBC.

    Hydrostatic pressure induces osteogenic differentiation of adipose-derived mesenchymal stem cells through increasing lncRNA-PAGBC.
    Ru J, Guo L, Ji Y, Niu Y., Free PMC Article

    03/13/2021
    Authors establish that LINC01133 is sufficient, on its own, in promoting phenotypic and growth characteristics of cancer stem cell-like cells, and that it is a direct mediator of the MSC-triggered miR-199a-FOXP2 pathway in TNBC models.

    Microenvironmental Regulation of Long Noncoding RNA LINC01133 Promotes Cancer Stem Cell-Like Phenotypic Traits in Triple-Negative Breast Cancers.
    Tu Z, Schmöllerl J, Cuiffo BG, Karnoub AE.

    08/1/2020
    we unveiled that LINC01133 may function as a ceRNA for miR-4784 to advance AHDC1 expression, intensifying CC cell malignant phenotypes and EMT process, which may demonstrate the implied value of LINC01133 as a therapeutic target for CC patients.

    LINC01133 promotes the progression of cervical cancer by sponging miR-4784 to up-regulate AHDC1.
    Feng Y, Qu L, Wang X, Liu C., Free PMC Article

    07/25/2020
    Study clarified the distinct effect of LINC01133 on pancreatic cancer. In summary, by inducing the methylation of DKK1 promoter, LINC01133 silencing suppresses the development of pancreatic cancer cells through the Wnt signaling pathway.

    Long non-coding RNA LINC01133 silencing exerts antioncogenic effect in pancreatic cancer through the methylation of DKK1 promoter and the activation of Wnt signaling pathway.
    Weng YC, Ma J, Zhang J, Wang JC., Free PMC Article

    05/23/2020
    The knockdown of LINC01133 dramatically repressed hepatocellular carcinoma tumor progression through targeting the PI3K/AKT pathway in vivo.

    LINC01133 aggravates the progression of hepatocellular carcinoma by activating the PI3K/AKT pathway.
    Zheng YF, Zhang XY, Bu YZ.

    04/11/2020
    Because of its role as an miR-205 sponge, LINC01133 repressed the development of ovarian cancer by up-regulating LRRK2.

    Long Noncoding RNA LINC01133 Confers Tumor-Suppressive Functions in Ovarian Cancer by Regulating Leucine-Rich Repeat Kinase 2 as an miR-205 Sponge.
    Liu M, Shen C, Wang C.

    04/4/2020
    our findings revealed that the C/EBPbeta-LINC01133 axis performs an oncogenic function in pancreatic ductal adenocarcinoma by activating CCNG1

    The C/EBPβ-LINC01133 axis promotes cell proliferation in pancreatic ductal adenocarcinoma through upregulation of CCNG1.
    Huang CS, Chu J, Zhu XX, Li JH, Huang XT, Cai JP, Zhao W, Yin XY.

    04/27/2019
    tissue-specific down-regulation of PCAT18 and LINC01133 in gastric and other gastrointestinal cancers imply that these long noncoding RNAs may have a tumor suppressive function in the development of these tumor entities.

    Tissue-Specific Down-Regulation of the Long Non-Coding RNAs PCAT18 and LINC01133 in Gastric Cancer Development.
    Foroughi K, Amini M, Atashi A, Mahmoodzadeh H, Hamann U, Manoochehri M., Free PMC Article

    03/30/2019
    Findings suggest that reduced expression of LINC01133 is associated with aggressive tumor phenotypes and poor patient outcomes in gastric cancer (GC). LINC01133 inhibits GC progression and metastasis by acting as a ceRNA for miR-106a to regulate APC expression and the Wnt/beta-catenin pathway, suggesting that LINC01133 may serve as a potential prognostic biomarker.

    LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
    Yang XZ, Cheng TT, He QJ, Lei ZY, Chi J, Tang Z, Liao QX, Zhang H, Zeng LS, Cui SZ., Free PMC Article

    03/23/2019
    Data indicate that LINC01133 inhibited OSCC metastasis via a feedback regulation loop of reciprocal inhibition with GDF15.

    Long noncoding RNA LINC01133 inhibits oral squamous cell carcinoma metastasis through a feedback regulation loop with GDF15.
    Kong J, Sun W, Zhu W, Liu C, Zhang H, Wang H.

    12/29/2018
    Our results indicated that reduced LINC01133 expression contributed to colorectal cancer metastasis and poor prognosis

    Downregulation of long non-coding RNA LINC01133 is predictive of poor prognosis in colorectal cancer patients.
    Zhang JH, Li AY, Wei N.

    07/7/2018
    firstprevious page of 2 nextlast